-4%

MOTS-C 40mg

Semaglutide 10mg

MOTS-C 40mg

Original price was: $140.00.Current price is: $135.00.

In stock

Original price was: $140.00.Current price is: $135.00.

Categories: ,

Description

Novum BioScience MOTS-C 40mg

MOTS-c is a mitochondrial-derived peptide that has emerged as a key regulator of metabolic function and cellular homeostasis. Composed of just 16 amino acids, this small peptide is encoded within the mitochondrial DNA rather than nuclear DNA, distinguishing it from most other bioactive peptides in the body.

The peptide works by translocating to the nucleus under metabolic stress, where it regulates gene expression to improve metabolic flexibility and insulin sensitivity. MOTS-c activates the AMPK pathway, enhances glucose uptake, and promotes fatty acid oxidation, making it a powerful metabolic regulator that helps the body adapt to changing energy demands and maintain homeostasis.

MOTS-C is generally well-tolerated, with most reported side effects being mild and dose-dependent.  The most common issues include mild injection-site reactions (redness, irritation, or swelling), temporary fatigue, and occasional headaches. 

Other potential side effects include:

  • Metabolic shifts: Temporary fluctuations in blood sugar, which may cause dizziness or lightheadedness, particularly in fasting states. 

  • Gastrointestinal discomfort: Mild nausea or digestive upset, though this is less common than with other metabolic peptides. 

  • Appetite changes: Users may experience decreased appetite or unintentional weight loss due to enhanced fat oxidation. 

  • Cardiovascular effects: Some self-experimenters report increased heart rate or palpitations, though this is not universally reported. 

  • Sleep disturbances: Insomnia has been noted in some anecdotal reports. 

Important Context: Long-term human safety data is limited as MOTS-C is not FDA-approved and remains a research peptide.  Severe side effects are rare, but users are advised to start with low doses, monitor blood sugar levels, and consult a healthcare professional, especially if they have pre-existing metabolic conditions or are taking medications like metformin. 

Common research-planning tiers include:

  • Starting Tier: 5 mg administered twice weekly for 4 weeks to assess tolerance. 

  • Standard Tier: 5 mg administered three times weekly for 4–6 weeks. 

  • Higher Tier: 10 mg administered 2–3 times weekly for 6–8 weeks. 

Alternative protocols found in community guides include:

  • 20-Day Cycle: 5 mg injected once every 5 days (4 total injections), followed by a 4-month rest. 

  • Daily Titration: Starting at 200–500 mcg daily and gradually increasing to 1–2 mg daily over 8–12 weeks. 

  • Conservative: 1 mg administered 5 days on, 2 days off for 8 weeks. 

Most users report cumulative metabolic effects rather than acute changes, with typical cycles lasting 8 to 12 weeks followed by a break period.  Side effects may include injection-site reactions, flushing, or mild fatigue. Consult a healthcare provider before use, as MOTS-c is prohibited by WADA.